Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 33.33% vs 500.00% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 42.86% vs 3.45% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 54.55% vs 4.35% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of DanCann Pharma A/S With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 33.33% vs 500.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -15.79% vs 18.75% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 42.86% vs 3.45% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 44.83% vs -31.82% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 54.55% vs 4.35% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -11.11% vs 70.00% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -66.67% vs -70.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






